Insider Transactions in Q2 2017 at Ra Pharmaceuticals, Inc. (RARX)
Insider Transaction List (Q2 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 19
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,220
-0.14%
|
$70,840
$22.02 P/Share
|
|
Jun 16
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53,200
-2.31%
|
$1,117,200
$21.24 P/Share
|
|
Jun 08
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
700
-0.03%
|
$15,400
$22.0 P/Share
|
|
Jun 07
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,840
-0.21%
|
$106,480
$22.11 P/Share
|
|
Jun 06
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,274
-0.31%
|
$160,028
$22.98 P/Share
|
|
Jun 05
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,780
-0.21%
|
$109,940
$23.11 P/Share
|
|
Jun 02
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,867
-0.64%
|
$341,941
$23.47 P/Share
|
|
Jun 01
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,722
-0.46%
|
$246,606
$23.89 P/Share
|
|
May 31
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
35,539
-1.49%
|
$817,397
$23.94 P/Share
|
|
May 26
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,300
-0.22%
|
$132,500
$25.14 P/Share
|
|
May 25
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53
-0.0%
|
$1,325
$25.0 P/Share
|
|
May 24
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,451
-0.72%
|
$436,275
$25.01 P/Share
|
|
May 18
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,019
-0.37%
|
$225,475
$25.5 P/Share
|
|
May 17
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,534
-0.92%
|
$563,350
$25.51 P/Share
|
|
May 16
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,081
-0.82%
|
$522,106
$26.33 P/Share
|